Genzyme Corp. 3Q Revenues: $960 million (+19%) 3Q Earnings: $159 million (up from $16 million in 3Q06) YTD Revenues: $2.8 billion (+19%) YTD Earnings: $401 million (+60%) Comments: Myzozyme sales rose 162% to $54 million in 3Q07, and the company is hoping to gain approval for a new large-scale manufacturing process in the U.S. Fabrazyme sales grew 12% to $105 million and Cerezyme was up 13% to $286 million. Genzyme expanded its line this quarter by acquiring several new products a...